- |||||||||| levetiracetam / Generic mfg., methylprednisolone sodium succinate / Generic mfg.
DRESS, a Serious Reaction from Levetiracetam Seizure Prophylaxis in TBI () - Feb 11, 2020 - Abstract #ISPRM2020ISPRM_776; This patient demonstrates that serious complications, such as DRESS syndrome may occur with levetiracetam within 8 weeks of initiation. Conclusions : Physiatrists should be aware of DRESS syndrome as a severe drug induced reaction of levetiracetam and be mindful in using antiepileptics to prevent early posttraumatic seizures.
- |||||||||| desipramine / Generic mfg.
Desipramine withdrawal syndrome complicating recovery from hypoxic-ischemic brain injury: Acase study () - Feb 11, 2020 - Abstract #ISPRM2020ISPRM_730; Conclusions : To our knowledge, this is the first reported case of desipramine exacerbating post-hypoxic myoclonus, likely through the effects of one or both of serotonin or norepinephrine. In this complex case, where rehabilitation treatments for cognitive, motor, and mood symptoms were both overlapping and conflicting, identifying and addressing desipramine withdrawal paved the way for a better functional outcome.
- |||||||||| risperidone / Generic mfg., Egis, cyclophosphamide intravenous / Generic mfg., Rituxan (rituximab) / Roche, Biogen
Anti-NMDAR Encephalitis in a 9-year-old boy () - Feb 11, 2020 - Abstract #ISPRM2020ISPRM_486; Patient was diagnosed with Anti-NMDA receptor encephalitis (ANRE) and treated with a regimen of high-dose pulse solumedrol followed by steroid taper, IVIG, rituximab, and cytoxan...He had a lengthy rehabilitation course which was complicated by severe agitation requiring risperidone and ativan...Early recognition of this condition is important to prevent treatment delay and to improve prognosis. Prompt treatment and proper agitation management allows for improved rehabilitation progress and clinical outcomes.Conclusions : Early recognition of ANRE allows for prompt treatment and improved patient recovery, rehabilitation, and clinical outcomes.
- |||||||||| levetiracetam / Generic mfg.
Phase classification: Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia (clinicaltrials.gov) - Feb 10, 2020 P1/2, N=50, Recruiting, This case study aims to describe myoclonus as a sequela of hypoxic brain injury, to suggest potential pharmacologic treatment of post-hypoxic myoclonus, and to spread awareness of this uncommon, yet clinically significant syndrome in the inpatient rehabilitation setting. Phase classification: P=N/A --> P1/2
- |||||||||| levetiracetam / Generic mfg.
Review, Journal: Epilepsy in brain metastasis: an emerging entity. (Pubmed Central) - Feb 10, 2020 New preclinical and clinical studies should define the risk of brain metastasis in light of the new treatment options in the different tumor types. New clinical trials should be designed in patients with brain metastases in terms of treatment or prophylaxis of seizures.
- |||||||||| levetiracetam / Generic mfg., topiramate / Generic mfg., lamotrigine liquid oral suspension / OWP Pharma
Journal: Management of epilepsy in brain tumors. (Pubmed Central) - Feb 8, 2020 Management of seizures in patients with BTE should be multidisciplinary. The panel evidenced conflicting or lacking data regarding the role of EEG, the choice of therapeutic strategy, and timing to withdraw AEDs and recommended high-quality long-term studies to standardize BTE care.
- |||||||||| levetiracetam / Generic mfg.
Journal, Adverse events: Rhabdomyolysis: a rare adverse effect of levetiracetam. (Pubmed Central) - Feb 8, 2020 Within 12 hours of withdrawal of levetiracetam, there was a downward trend in the CPK levels, with a 10-fold decrease in CPK levels over the next 4 days. This is only the ninth case reported in literature regarding this rare and potentially serious adverse effect of levetiracetam.
- |||||||||| lacosamide / Generic mfg., levetiracetam / Generic mfg.
Clinical, Journal: A Rare Case of Prolonged Ictal Aphasia. (Pubmed Central) - Feb 7, 2020 In this case, aphasia was determined to be an ictal semiology, as patient had complete resolution of his symptoms supported by a normal EEG after receiving seizure medications. We suggest keeping high suspicion for an ictal process in patients with sudden-onset aphasia supported by EEG findings of LPDs.
- |||||||||| methylprednisolone oral / Generic mfg.
Journal: Syncope and Twitching at the Emergency Department. (Pubmed Central) - Feb 7, 2020 Sinus arrest may occur because of a direct pathophysiological dysfunction of the structures involved in autonomic cardiac rhythm control or as an ictal or postictal phenomenon. Early diagnosis and initiation of immunosuppressive therapy are both of utmost importance for favorable clinical outcome.
- |||||||||| levetiracetam / Generic mfg., acarbose / Generic mfg.
Post-Bariatric Hypoglycemia: A Clinical Vignette on an Increasingly Recognized Disease (ENDOExpo) - Feb 7, 2020 - Abstract #ENDO2020ENDO_3222; By bypassing normal anatomy, gastric emptying is increased 2-3 x, which leads to a higher and more rapid appearance of glucose in the distal foregut. This subsequently leads to an amplified incretin response leading to a hyperinsulinemic response in patients who have had bariatric surgery; however, for unclear reasons some patients develop an even more amplified hyperinsulinemic response that leads to subsequent hypoglycemia.
- |||||||||| Fycompa (perampanel) / Eisai, Catalyst Pharma, Ospolot (sultiam) / AOP Orphan Pharma, Diacomit (stiripentol) / Biocodex, Meiji Seika
Trial completion date, Trial primary completion date: EPIPOP: Population Pharmacokinetics of Antiepileptic in Pediatrics (clinicaltrials.gov) - Feb 5, 2020 P=N/A, N=1000, Recruiting, Recruiting --> Active, not recruiting | Trial primary completion date: May 2020 --> Jan 2020 Trial completion date: Jun 2019 --> Jun 2022 | Trial primary completion date: Jun 2019 --> Jun 2022
- |||||||||| ethosuximide / Generic mfg.
Preclinical, Journal: Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary. (Pubmed Central) - Jan 30, 2020 Levetiracetam was found to be associated with a higher incidence of subclinical depression which needs further investigation. Overall, these results demonstrate that the antiepileptogenic effects of both ethosuximide and levetiracetam on absence seizure development and associated depressive-like behaviour in this model are only temporary.
- |||||||||| levetiracetam / Generic mfg.
Journal, Adverse events: Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events. (Pubmed Central) - Jan 29, 2020 Our results suggest that SV2A expression in tumoral and peritumoral tissue correlates with the occurrence of LEV-related NPAEs. Thus, considering that SV2A expression also influences LEV effectiveness, SV2A staining might help in tailoring treatment to patients.
- |||||||||| levetiracetam / Generic mfg.
A case of isolated and prolonged aphasic status epilepticus () - Jan 21, 2020 - Abstract #AAN2020AAN_2400; Similar to our patient, previous case reports revealed that patients with epileptic aphasia may retain some aphasic deficits for several days or even weeks after the ictal EEG pattern has resolved. It is not clear if the slow recovery is the result of a prolonged postictal “Todd’s” phenomenon or ongoing seizures not detectable on scalp electrodes.
- |||||||||| carbamazepine / Generic mfg., Trileptal (oxcarbazepine) / Novartis
Anti-Epileptic Drug Psychiatric Adverse Events in Focal Epilepsy-A Cohort Study () - Jan 21, 2020 - Abstract #AAN2020AAN_2073; CBZ and LTG are more tolerable, psychiatrically. Several limitations of this study include: missing data and many confounding variables could affect depressive scores during the study period.
- |||||||||| Trileptal (oxcarbazepine) / Novartis
An Online Survey of Caregivers of Patients with SCN8A-related epilepsy () - Jan 21, 2020 - Abstract #AAN2020AAN_2006; SCN8A-related epilepsy is a highly variable disorder. There is no current standard of care and existing therapies appear to have a high failure rate with the majority of patients experiencing continuing intractable seizures.
- |||||||||| levetiracetam / Generic mfg., topiramate / Generic mfg., Cerebyx (fosphenytoin) / Pfizer, Nobelpharma
The Use of Midazolam for Refractory Neonatal Seizures () - Jan 21, 2020 - Abstract #AAN2020AAN_1999; Birth characteristics are not predictive of seizure response to medications. Use of two seizure medications prior to midazolam infusion, and three seizure medications in the group not requiring midazolam were associated with worse outcomes.
- |||||||||| levetiracetam / Generic mfg.
Vaping and Seizure Risk: A Case Report () - Jan 21, 2020 - Abstract #AAN2020AAN_1902; There may be a connection with e-cigarette exposure and seizures. Additional information is required to determine if a link exists between vaping and seizures.
- |||||||||| Vimpat (lacosamide) / UCB, Daiichi Sankyo, levetiracetam / Generic mfg.
Outcome of Epilepsy in Older Adults; Preliminary Analysis () - Jan 21, 2020 - Abstract #AAN2020AAN_1740; Levetiracetam, Lamotrigine and Lacosamide were the most commonly utilized ASDs in the elderly patients. Lamotrigine monotherapy was most often associated with seizure free state.
- |||||||||| Fycompa (perampanel) / Eisai
Adjunctive Perampanel in Refractory Status Epilepticus (RSE): A Report of Two Cases. () - Jan 21, 2020 - Abstract #AAN2020AAN_1695; Both our patients with RSE were successfully weaned off the anesthetic drug with introduction of Perampanel. The use of Perampanel in this manner deserves further study to determine its efficacy and safety, more quantitatively as an adjunctive therapy for RSE.
|